AIDSVAX^® Program:  Current Trials

GSID serves the manufacturing and product sponsor for the AIDSVAX^® B/E vaccine, which continues to be used in a number of HIV vaccine trials around the world. The following table represents the current and planned trials:

AIDSVAX® B/E Clinical Trials

Study Protocol Phase Study Location Clinical Trial Sponsor Priming Vaccine Study Status RV 305 2 Thailand US Surgeon General / Dept. of the Army Sanofi Pasteur ALVAC vCP1521 Completed RV 305A 2 Thailand US Surgeon General / Dept. of the Army AIDSVAX B/E boost only Completed RV 306 2 Thailand US Surgeon General / Dept. of the Army Sanofi Pasteur ALVAC vCP1521 Completed RV 328 2 Thailand US Surgeon General / Dept. of the Army None / AIDSVAX B/E alone Completed HVTN 096/EV04 1 Switzerland EuroVacc Foundation EuroVacc NYVAC HIV-PT1, NYVAC HIV-PT4, IPPOX DNA-HIV-PT123 Completed* HVTN 097 1b Republic of South Africa NIH/NIAID/DAIDS Sanofi Pasteur ALVAC vCP1521 Completed* HVTN 105 1b USA NIH/NIAID/DAIDS iPox DNA-HIV-PT123 Completed* HVTN 110 1 USA PaxVax Inc. PaxVax Ad4 mgag/Env C150 Completed HVTN 114 1 USA / Peru NIH/NIAID/DAIDS GeoVax MVA/HIV62B Ongoing HVTN121 1 USA NIH/NIAID/DAIDS AIDSVAX B/E alone In Planning HVTN 126 1b Republic of South Africa NIH/NIAID/DAIDS Late boost comparison with 1086.C w/alum In Planning PXVX-HIV-100-001 1b USA PaxVax Inc. PaxVax Ad4 mgag/Env C150 Ongoing EV06 1 Uganda EuroVacc Foundation IPPOX DNA-HIV-PT123 Completed* EV07  1 Uganda EuroVacc Foundation IPPOX DNA-HIV-PT123 Ongoing

* Publications pending Study Status as of June 1, 2017

 

Additional Resources

• AIDSVAX^® Program: Overview
• VaxGen Trials
• RV144 Trials
• Current Trials
• AIDSVAX^® Collaborators
  
  
  
  
  

CNN International provides an update on the PrEPVacc clinical trial
[more]